The function of P2X3 receptor and NK1 receptor antagonists on cyclophosphamide-induced cystitis in rats

被引：0
|
作者：
Hui-ping Zhang
Cui-ling Li
Peng Lu
Jia-cui Zheng
Li–li Yu
Wei-min Yang
Fei Xiong
Xiao-yong Zeng
机构：
[1] Huazhong University of Science and Technology,Family Planning Research Institute, Tongji Medical College
[2] Huazhong University of Science and Technology,Department of Urology, Tongji Hospital, Tongji Medical College
[3] Yichang Central Hospital,Department of Urology
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Cyclophosphamide; Cystitis; Urodynamics; P2X3; NK1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：91 / 97
页数：6
相关论文
共 50 条
  • [21] Regulation of P2X3 Receptor Structure and Function
    Fabbretti, Elsa
    Nistri, Andrea
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (06) : 687 - 698
  • [22] Treatment of chronic cough: P2X3 receptor antagonists and beyond
    Sykes, Dominic L.
    Zhang, Mengru
    Morice, Alyn H.
    PHARMACOLOGY & THERAPEUTICS, 2022, 237
  • [23] Discovery of P2X3 receptor antagonists for the treatment of chronic pain
    Burgey, Christopher S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [24] Discovery of orally bioavailable NK1 receptor antagonists
    Genicot, C
    Christophe, B
    Collart, P
    Gillard, M
    Goossens, L
    Hénichart, JP
    Lassoie, MA
    Moureau, F
    Neuwels, M
    Nicolas, JM
    Pasau, P
    Quéré, L
    Ryckmans, T
    Stiernet, F
    Taverne, T
    Van Keulen, BJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 437 - 442
  • [25] Design and synthesis of potential dual NK1/NK3 receptor antagonists
    Hanessian, Stephen
    Babonneau, Vincent
    Boyer, Nicolas
    la Cour, Clotilde Mannoury
    Millan, Mark J.
    De Nanteuil, Guillaume
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (02) : 510 - 514
  • [26] CHARACTERIZATION OF THE BINDING OF NONPEPTIDE ANTAGONISTS TO THE NK1 RECEPTOR
    MCLEAN, S
    DESAI, MC
    ROSEN, T
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S84 - S84
  • [27] New insights into the antidepressant actions of substance P (NK1 receptor) antagonists
    Rupniak, NMJ
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (05) : 489 - 494
  • [28] Why are substance P (NK1)-receptor antagonists ineffective in pain therapy?
    Herbert, MK
    Holzer, P
    ANAESTHESIST, 2002, 51 (04): : 308 - 319
  • [29] Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists
    Mah, R
    Gerspacher, M
    von Sprecher, A
    Stutz, S
    Tschinke, V
    Anderson, GP
    Bertrand, C
    Subramanian, N
    Ball, HA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (16) : 2065 - 2068
  • [30] Olanzapine and NK1 receptor antagonists for the prevention of chemotherapy induced delayed emesis
    Navari, R
    Passik, S
    Kirsh, K
    PSYCHO-ONCOLOGY, 2003, 12 (04) : S146 - S146
12345